ASSIGNMENT AND EXCHANGE AGREEMENTAssignment and Exchange Agreement • November 27th, 2023 • Biodexa Pharmaceuticals PLC • Pharmaceutical preparations • New York
This ASSIGNMENT AND EXCHANGE AGREEMENT (this “Agreement”), dated as of November 22, 2023, is entered into by and among Biodexa Pharmaceuticals PLC, a public limited company organized under the laws of England and Wales (“Buyer”), and Adhera Therapeutics, Inc., a Delaware corporation (the “Company”), and the holders of secured notes issued by the Company set forth on Schedule 1 hereto (the “Secured Noteholders”). The Company, Buyer and the Secured Noteholders are sometimes referred to herein collectively as the “Parties” and each individually as a “Party.” Capitalized terms used herein but not otherwise defined shall have the meaning set forth in Article I.
ASSIGNMENT AND EXCHANGE AGREEMENTAssignment and Exchange Agreement • April 6th, 2016 • Epic Stores Corp. • Retail-miscellaneous retail • New York
THIS ASSIGNMENT AND EXCHANGE AGREEMENT (the “Agreement”) is dated this 1st day of April, 2016 (the “Effective Date”), by and among Old Main Capital, LLC (the “Holder”), Epic Stores Corp. (the “Company”) and Epic Stores LLC, a wholly-owned subsidiary of the Company (the “Subsidiary”).
ASSIGNMENT AND EXCHANGE AGREEMENTAssignment and Exchange Agreement • November 29th, 2023 • Adhera Therapeutics, Inc. • Pharmaceutical preparations • New York
This ASSIGNMENT AND EXCHANGE AGREEMENT (this “Agreement”), dated as of November 22, 2023, is entered into by and among Biodexa Pharmaceuticals, PLC, a public limited company organized under the laws of England and Wales (“Buyer”), and Adhera Therapeutics, Inc., a Delaware corporation (the “Company”), and the holders of secured notes issued by the Company set forth on Schedule 1 hereto (the “Secured Noteholders”). The Company, Buyer and the Secured Noteholders are sometimes referred to herein collectively as the “Parties” and each individually as a “Party.” Capitalized terms used herein but not otherwise defined shall have the meaning set forth in Article I.
Biodexa Pharmaceuticals PLCAssignment and Exchange Agreement • November 29th, 2023 • Adhera Therapeutics, Inc. • Pharmaceutical preparations
Reference is made to that certain Assignment and Exchange Agreement, dated as of the date hereof, by and among Biodexa Pharmaceuticals PLC, a public limited company organized under the laws of England and Wales (“Buyer”), Adhera Therapeutics, Inc., a Delaware corporation (the “Company”), and the holders of secured notes issued by the Company set forth on Schedule 1 thereto (the “Agreement”). Capitalized terms used, but not otherwise defined, herein shall have the meaning given to such terms in the Agreement.
